Purchase Order 36C25025P1418

Award Date 8/1/25
Potential Completion Date 7/31/30
Potential Value $75K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cincinnati, OH 45220, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a sole source, firm-fixed price contract awarded by the Department of Veterans Affairs (VA), Veterans Health Administration, Network Contracting Office 10 in Cincinnati, Ohio to Diasorin Molecular, LLC. The $15,118 contract is for a Diasorin Liaison MDX service agreement to support the Cincinnati VA Medical Center. The contract has a performance period through July 31, 2025. Diasorin Molecular is a foreign-owned, for-profit manufacturer of medical diagnostic products and testing...
This firm-fixed-price delivery order was awarded by the Department of Veterans Affairs Veterans Health Administration to Diasorin Molecular, LLC, a foreign-owned manufacturer of medical diagnostic products and testing equipment. The $11,688 contract provides COVID-19 tests, analyzers, and related laboratory equipment and maintenance services to support the agency's pandemic response efforts across VA medical centers. Diasorin Molecular, LLC is a prime contractor on several federal contracts with...
Diasorin Molecular LLC has been awarded a firm-fixed price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 for $220,040.76 to provide Diasorin reagents and supplies for COVID-19 testing through December 2022. The award was issued on December 21, 2021 without a set-aside designation. Diasorin Molecular LLC will deliver the requested reagents and supplies to support coronavirus disease testing at VA medical facilities in...
Diasorin Molecular LLC has been awarded a $9,467.20 firm-fixed-price delivery order against the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 single-award indefinite delivery contract to provide COVID-19 diagnostic tests and analyzers in Cypress, California. The delivery order has a completion date of September 30, 2026 and was awarded on October 1, 2022. The contract vehicle was awarded without a set-aside designation to support the VA's...
This is a firm-fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Diasorin Molecular LLC, a foreign-owned for-profit manufacturer of medical diagnostic products and testing equipment. The contract, valued at $73,226.83, is for Diasorin's Simplexa molecular diagnostic tests and analyzers to support COVID-19 testing and surveillance at VA medical facilities in California and Minnesota. The contract is not set aside and was issued under a...
This federal contract award to Diasorin Molecular, LLC, a foreign-owned, for-profit manufacturer of medical diagnostic products and testing equipment, was made by the U.S. Department of Veterans Affairs (VA) through Veterans Integrated Service Network (VISN) 23. The $169,000.00 Firm Fixed Price delivery order contract, which does not have a set-aside designation, is for the provision of COVID-19 tests and analyzers to support the VA's pandemic response and ongoing infectious disease testing...
This federal contract award to Diasorin Molecular LLC, a foreign-owned for-profit manufacturer of medical diagnostic products, is for the provision of the LIAISON MDX System and related reagents to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration. The $101,552 firm-fixed-price purchase order, which was not set aside, supports the VA's COVID-19 pandemic response efforts. Through this and other contracts, Diasorin Molecular LLC has supplied COVID-19 diagnostic tests,...
The Department of the Army Medical Command awarded a firm-fixed price purchase order contract to Diasorin Molecular LLC, a foreign-owned for-profit manufacturer of medical diagnostic products and testing equipment. The $537,535.00 contract is for chemistry testing services, with a completion date of September 30, 2022. Diasorin Molecular LLC has provided molecular diagnostic tests, reagents, and laboratory instrumentation to support infectious disease testing and surveillance for the...
This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration's Veterans Integrated Service Network 10 (VISN 10) to Diasorin Molecular, LLC, a foreign-owned, for-profit manufacturer of medical diagnostic products and testing equipment. The $552,071.87 firm fixed-price purchase order is for the delivery of Simplexa COVID-19 Direct Kits and Simplexa COVID-19 Positive Control Packs through October 31, 2026. This sole-source award was made under simplified...
This federal contract award to Diasorin Molecular, LLC, a foreign-owned, for-profit manufacturer of medical diagnostic products, is for the delivery of COVID-19 tests and analyzers to the Veterans Integrated Service Network (VISN) 23 of the Department of Veterans Affairs (VA). The contract, valued at $498,757.12, is a Firm Fixed Price Delivery Order with a period of performance through September 30, 2023. This award is part of a larger $10 million single-award Indefinite Delivery Vehicle (IDV)...

This is a $75,000.00 firm-fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 10 to Diasorin Molecular, LLC, a foreign-owned, for-profit medical diagnostic manufacturer. The contract is for a Diasorin Molecular MDX service agreement to support the Cincinnati VA Medical Center. It is a base period with four option periods, running from August 1, 2025 through July 31, 2030. Diasorin Molecular, headquartered in Cypress, California, is a key supplier of diagnostic technologies, including COVID-19 and other infectious disease testing solutions, to federal healthcare agencies. The contract award did not utilize any set-aside designations.

Generated 10/1/25, 10:11 AM